Alzheimer's Disease Program

En Español 

Alzheimer's disease (AD) is a progressive brain disease and is becoming a major public health issue in the United States. An estimated 5.7 million Americans of all ages are living with Alzheimer’s disease in 2018. This includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s. In Texas, 380,000 people age 65 and older have Alzheimer’s. Unless a cure or prevention is found, the number of Americans age 65 and older with Alzheimer's may nearly triple to a projected 13.8 million people by 2050.

Alzheimer's is a disease of the brain that causes a steady decline in memory, thinking and behavior that is severe enough to interfere with everyday life. How rapidly the disease progresses varies from person to person, but all affected individuals experience confusion, personality changes, impaired judgment, and eventually can no longer care for themselves. Alzheimer's disease is a terminal illness. As the disease progresses, more and more of the brain is affected. Eventually the areas that control basic life functions, like swallowing and breathing, become irreversibly damaged. 

The Alzheimer’s Disease Program of the Texas Department of State Health Services increases awareness of the disease and addresses its burden on individuals living with Alzheimer’s disease, those who care for them, and related professionals through strategic planning with statewide partnerships. 

To learn more, visit the Alzheimer's Disease Program Q&A

Alzheimer's Disease Publications

Texas Council on Alzheimer’s Disease and Related Disorders Biennial Report 2018

Texas State Plan on Alzheimer's Disease 2010-2015

Clinica Best Practices for the Early Detection, Diagnosis, and Pharmaceutical and Non- Pharmaceutical Treatment of Persons with Alzheimer's Disease Cover

View the Texas Council on Alzheimer's Disease and Related Disorders 2018 Biennial Report 

View the Texas State Plan on Alzheimer's Disease 2010-2015 (PDF, 1 mb)
Publication Number:

Clinical Best Practices for the Early Detection, Diagnosis, and Pharmaceutical and Non-Pharmaceutical Treatment of Persons with Alzheimer’s Disease (PDF 1 mb)

Download the 2018 Alzheimer’s Association Facts and Figures Report (PDF)

Last updated October 29, 2018